DBICX | MBXAX | DBICX / MBXAX | |
Total Expense Ratio | 2.09 | 2.28 | 92% |
Annual Report Gross Expense Ratio | 2.14 | 2.28 | 94% |
Fund Existence | 24 years | 9 years | - |
Gain YTD | 5.696 | -2.076 | -274% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 172M | 8.05B | 2% |
Annual Yield % from dividends | 1.26 | 1.71 | 74% |
Returns for 1 year | 4.81 | -0.59 | -819% |
Returns for 3 years | 11.10 | 6.09 | 182% |
Returns for 5 years | 18.40 | 51.04 | 36% |
Returns for 10 years | 35.50 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JLVIX | 70.17 | N/A | N/A |
JHancock Fundamental Large Cap Core I | |||
GSMGX | 13.58 | N/A | N/A |
Goldman Sachs Small/Mid Cap Growth C | |||
WSCGX | 33.30 | N/A | N/A |
Allspring Small Company Growth Inst | |||
SHPCX | 12.71 | N/A | N/A |
Saratoga Health & Biotechnology C | |||
MAIHX | 18.98 | N/A | N/A |
Morgan Stanley Inst Passport ovrs eq IR |